Overview
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Status:
Terminated
Terminated
Trial end date:
2008-01-01
2008-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Solvay Pharmaceuticals
Criteria
Inclusion Criteria:- Diagnosis of dementia of the Alzheimer's type
Exclusion Criteria:
- History of seizure disorder
- Clinically significant electrocardiogram (ECG)
- Clinical or radiological evidence of stroke, vascular dementia or dementia due to
substance abuse, or head trauma